4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-23-042646
Chief Executive Officer sold 12,000 shares at $28.54 ($342,480)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2023-12-20 | Sale 10b5-1 | −12,000 | $28.54 | $342,480 | 3,725,000 | D |
| Open-market sales · 12,000 sh · avg $28.54 · $342,480 | |||||||
Loading xslF345X05/wk-form4_1703282656.xml…